Comparison between Mahamaya Lifesciences IPO and MARC Technocrats IPO.
Mahamaya Lifesciences IPO is a SME Bookbuilding IPO proposed to list at BSE SME while MARC Technocrats IPO is a SME Bookbuilding proposed to list at NSE SME.
| Mahamaya Lifesciences IPO | MARC Technocrats IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Mansi Share & Stock Broking Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mahamaya Lifesciences IPO is up to ₹66.91 Cr whereas the issue size of the MARC Technocrats IPO is up to ₹40.37 Cr. The final issue price of Mahamaya Lifesciences IPO is ₹114.00 per share and of MARC Technocrats IPO is ₹93.00 per share.
| Mahamaya Lifesciences IPO | MARC Technocrats IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹108.00 per share | ₹88.00 per share |
| Issue Price (Upper) | ₹114.00 per share | ₹93.00 per share |
| Issue Price (Final) | ₹114.00 per share | ₹93.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 53,29,200 shares | 34,30,800 shares |
| Fresh Issue Size (Amount) | up to ₹60.75 Cr | up to ₹31.91 Cr |
| OFS Issue Size | 5,40,000 shares | 9,09,600 shares |
| OFS Issue Size (Amount) | up to ₹6.16 Cr | up to ₹8.46 Cr |
| Issue Size Total | 58,69,200 shares | 43,40,400 shares |
| Issue Size Total (Amount) | up to ₹66.91 Cr | up to ₹40.37 Cr |
Mahamaya Lifesciences IPO opens on Nov 11, 2025, while MARC Technocrats IPO opens on Dec 17, 2025. The closing date of Mahamaya Lifesciences IPO and MARC Technocrats IPO is Nov 13, 2025, and Dec 19, 2025, respectively.
| Mahamaya Lifesciences IPO | MARC Technocrats IPO | |
|---|---|---|
| Anchor Bid Date | Nov 10, 2025 | |
| Issue Open | Nov 11, 2025 | Dec 17, 2025 |
| Issue Close | Nov 13, 2025 | Dec 19, 2025 |
| Basis Of Allotment (Tentative) | Nov 14, 2025 | Dec 22, 2025 |
| Initiation of Refunds (Tentative) | Nov 17, 2025 | Dec 23, 2025 |
| Credit of Share (Tentative) | Nov 17, 2025 | Dec 23, 2025 |
| Listing date (Tentative) | Nov 18, 2025 | Dec 24, 2025 |
| Anchor Lockin End date 1 | Dec 13, 2025 | |
| Anchor Lockin End date 2 | Feb 11, 2026 |
Mahamaya Lifesciences IPO P/E ratio is 15.65, as compared to MARC Technocrats IPO P/E ratio of 16.97.
| Mahamaya Lifesciences IPO | MARC Technocrats IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Mahamaya Lifesciences Ltd.'s revenue increased by 64% and profit after tax (PAT) rose by 148% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)MARC Technocrats Ltd.'s revenue increased by 80% and profit after tax (PAT) rose by 117% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 77.27 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 56.35 | 73.55 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 15.65 | 16.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹266.82 Cr. | ₹161.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.94% | 31.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 23.15% | 35.63% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.08 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.29 | ₹5.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 26.19% | 31.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mahamaya Lifesciences IPO Retail Individual Investors (RII) are offered 20,59,200 shares while in MARC Technocrats IPO retail investors are offered 20,59,200 shares. Qualified Institutional Buyers (QIB) are offered 11,76,000 shares in Mahamaya Lifesciences IPO and 46,800 shares in MARC Technocrats IPO.
| Mahamaya Lifesciences IPO | MARC Technocrats IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,52,000 shares | 0 shares |
| Market Maker Reservation | 3,09,600 shares | 2,38,800 shares |
| QIB | 11,76,000 shares | 46,800 shares |
| NII | 8,82,000 shares | 21,45,600 shares |
| RII | 20,59,200 shares | 21,48,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 58,69,200 shares | 43,40,400 shares |
Mahamaya Lifesciences IPO subscribed 1.63x in total, whereas MARC Technocrats IPO subscribed 9.87x.
| Mahamaya Lifesciences IPO | MARC Technocrats IPO | |
|---|---|---|
| QIB (times) | 1.19x | 9.51x |
| NII (times) | 3.63x | 8.99x |
| Big NII (times) | 5.00x | 10.18x |
| Small NII (times) | 0.90x | 6.61x |
| RII (times) | 1.02x | 10.75x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.63x | 9.87x |
